Chronic Lymphocytic Leukemia
📧 Sign up to get email alerts when something new happens for Chronic Lymphocytic Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-07-05Clinical Trial Update: Adoptive Cell Therapy for B-Cell Cancers in Patients After Stem Cell Transplantation [Phase 1]
This Phase 1 trial evaluates adoptive cell therapy for B-cell cancers in patients after stem cell transplantation, focusing on chronic lymph…
-
CLINICAL_TRIALS research · 2018-07-02Clinical Trial Update: Massage Therapy Given by Caregiver in Treating Quality of Life of Young Patients Undergoing Treatment for Cancer [NA]
Clinical trial update on caregiver-delivered massage therapy to improve quality of life in pediatric cancer patients; the study (NCT01053494…
-
CLINICAL_TRIALS trial_result · 2018-07-02Clinical Trial Update: CPI-613, Bendamustine Hydrochloride, and Rituximab in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma [Phase 1]
Phase 1 trial evaluating a triple regimen of devimistat (CPI-613), bendamustine hydrochloride, and rituximab in relapsed or refractory B-cel…
-
CLINICAL_TRIALS trial_result · 2018-06-04Clinical Trial Update: AR-42 in Treating Patients With Advanced or Relapsed Multiple Myeloma, Chronic Lymphocytic Leukemia, or Lymphoma [Phase 1]
Phase 1 clinical trial update on AR-42 in adults with advanced or relapsed multiple myeloma, chronic lymphocytic leukemia, and various lymph…
-
CLINICAL_TRIALS trial_result · 2018-05-29Clinical Trial Update: Phase I Trial of Anti-CD74 (hLL1) Antibody Therapy in B Cell Malignancies [Phase 1]
Phase I trial update of milatuzumab (anti-CD74/hLL1) antibody therapy in B cell malignancies, including non-Hodgkin lymphoma and chronic lym…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-05-15Clinical Trial Update: A Safety and Efficacy Trial of a Combination of Bendamustine, Rituximab and Lenalidomide in Patients With Chronic Lymphocytic Leukemia [Phase 1, Phase 2]
A Phase 1/2 trial evaluating the three-drug combination of bendamustine, rituximab, and lenalidomide in chronic lymphocytic leukemia has com…
-
CLINICAL_TRIALS trial_result · 2018-05-11Clinical Trial Update: Cyclophosphamide and Total Body Irradiation in Treating Patients Who Are Undergoing an Autologous Peripheral Stem Cell Transplant For Chronic Lymphocytic Leukemia [Phase 2]
This Phase 2 trial evaluated cyclophosphamide with total body irradiation as conditioning before autologous peripheral stem cell transplant …
-
CLINICAL_TRIALS trial_result · 2018-05-11Clinical Trial Update: Bendamustine and Mitoxantrone in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia [Phase 2]
A phase 2 clinical trial evaluating the combination of bendamustine and mitoxantrone in patients with relapsed or refractory chronic lymphoc…
-
CLINICAL_TRIALS trial_result · 2018-05-11Clinical Trial Update: Fludarabine and Darbepoetin Alfa in Treating Older Patients With Chronic Lymphocytic Leukemia [Phase 3]
This Phase 3 trial evaluated the combination of fludarabine and darbepoetin alfa in older patients with chronic lymphocytic leukemia and ane…
-
CLINICAL_TRIALS trial_result · 2018-05-11Clinical Trial Update: Combination Chemotherapy Followed By Alemtuzumab in Treating Patients With Chronic Lymphocytic Leukemia or Prolymphocytic Leukemia [Phase 2]
A Phase 2 trial evaluating chemotherapy followed by Alemtuzumab for chronic lymphocytic leukemia or prolymphocytic leukemia has completed.
-
CLINICAL_TRIALS trial_result · 2018-04-30Clinical Trial Update: Tacrolimus, Bortezomib, & Thymoglobulin in Preventing Low Toxicity GVHD in Donor Blood Stem Cell Transplant Patients [Phase 2]
Phase 2 trial evaluating a three-drug regimen (Tacrolimus, Bortezomib, and Thymoglobulin) to prevent low-toxicity graft-versus-host disease …
-
CLINICAL_TRIALS trial_result · 2018-04-27Clinical Trial Update: Treatment With Bendamustine, Ofatumumab and MethylPrednisolone in Relapsed B-CLL [Phase 2]
A Phase 2 trial of bendamustine, ofatumumab and methylprednisolone for relapsed B-cell chronic lymphocytic leukemia has been terminated.
-
CLINICAL_TRIALS trial_result · 2018-04-23Clinical Trial Update: A Study of MabThera/Rituxan (Rituximab) in Combination With Fludarabine And Cyclophosphamide as Primary Therapy in Elderly Patients With Chronic Lymphocytic Leukemia [Phase 2]
A completed Phase 2 study evaluated rituximab with fludarabine and cyclophosphamide as initial therapy for elderly patients with chronic lym…
-
CLINICAL_TRIALS trial_result · 2018-04-23Clinical Trial Update: Bortezomib and Romidepsin in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma [Phase 1]
Phase 1 study evaluating the combination of bortezomib and romidepsin in patients with chronic lymphocytic leukemia or small lymphocytic lym…
-
CLINICAL_TRIALS trial_result · 2018-04-12Clinical Trial Update: Efficacy and Safety of Ibrutinib in Patients With CLL and Other Indolent B-cell Lymphomas Who Are Chronic Hepatitis B Virus Carriers or Occult Hepatitis B Virus Carriers [Phase 3]
Phase 3 trial update on the efficacy and safety of ibrutinib in patients with chronic lymphocytic leukemia and indolent B-cell lymphomas who…
-
CLINICAL_TRIALS trial_result · 2018-04-12Clinical Trial Update: Chronic Lymphocytic Leukemia Responds to Dermal Chelation [NA]
Clinical trial update reports that Chronic Lymphocytic Leukemia responds to dermal chelation therapy; the available details are limited.
-
CLINICAL_TRIALS trial_result · 2018-04-09Clinical Trial Update: Safety Study of CAT-8015 to Treat Advanced B-cell Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia (NHL or CLL) [Phase 1, Phase 2]
Phase 1/2 safety study of CAT-8015 in advanced B-cell non-Hodgkin lymphoma and chronic lymphocytic leukemia has completed enrollment with re…
-
CLINICAL_TRIALS withdrawal · 2018-04-05Clinical Trial Update: Evaluation of Splenic Irradiation in Chronic Lymphatic Leukemia
A clinical trial evaluating splenic irradiation for chronic lymphocytic leukemia has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2018-03-30Clinical Trial Update: BR in Patients With CLL With Comorbidities and/or Renal Dysfunction [Phase 1]
A Phase 1 clinical trial evaluating the bendamustine-rituximab (BR) regimen in patients with chronic lymphocytic leukemia or small lymphocyt…
-
CLINICAL_TRIALS trial_result · 2018-03-27Clinical Trial Update: Lenalidomide as Immune Adjuvant in Patient's With Chronic Lymphocytic Leukemia (CLL) [Phase 2]
Phase 2 trial update investigating lenalidomide as an immune adjuvant in patients with chronic lymphocytic leukemia (CLL); trial status term…
-
CLINICAL_TRIALS trial_result · 2018-03-22Clinical Trial Update: Retrospective Study: Efficacy and Safety of Chlorambucil + Rituximab in CLL Patients
A retrospective study evaluated the efficacy and safety of chlorambucil plus rituximab in chronic lymphocytic leukemia patients.
-
CLINICAL_TRIALS trial_result · 2018-03-20Clinical Trial Update: A Study of Rituximab in Combination With Fludarabine and Cyclophosphamide in Participants With Chronic Lymphocytic Leukemia and Favorable Somatic Status [Phase 4]
A Phase 4 study of rituximab in combination with fludarabine and cyclophosphamide in chronic lymphocytic leukemia was terminated; results we…
-
CLINICAL_TRIALS withdrawal · 2018-03-19Clinical Trial Update: Protocol to Obtain Blood for Discovery of Novel Biomarkers and Potential Therapeutic Targets in Chronic Lymphocytic Leukemia
Clinical trial NCT01069432, a protocol to obtain blood for discovery of biomarkers and potential therapeutic targets in chronic lymphocytic …
-
CLINICAL_TRIALS trial_result · 2018-03-15Clinical Trial Update: Ofatumumab and Dinaciclib in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or B-Cell Prolymphocytic Leukemia [Phase 1, Phase 2]
This clinical trial update reports completed Phase 1/Phase 2 studies evaluating the combination of ofatumumab and dinaciclib in patients wit…
-
CLINICAL_TRIALS trial_result · 2018-02-28Clinical Trial Update: Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of VAY736 in Relapsed or Refractory CLL Patients [Phase 1]
A Phase 1 study assessing safety, tolerability, PK and PD of VAY736 in relapsed or refractory chronic lymphocytic leukemia. The study status…